Agilon Health, Inc. Hits New 52-Week High at $133.00

Agilon Health, Inc. has reached a significant milestone by hitting a new 52-week high of USD 133.00 on July 17, 2026. This achievement underscores the company's remarkable performance over the past year, with a staggering increase of 1837.91%, significantly outpacing the S&P 500's growth of 18.43% during the same period. As a small-cap player in the Pharmaceuticals & Biotechnology industry, Agilon Health, Inc. has a market capitalization of USD 164 million. Despite its impressive stock performance, the company is currently loss-making, reflected in its P/E ratio, which is not applicable. The stock's price-to-book ratio stands at 1.30, indicating its valuation relative to its net assets. Agilon Health's financial metrics reveal a debt-to-equity ratio of -1.97 and a return on equity of -286.57%, highlighting the company's current financial structure. With no dividend yield, the focus remains on its stock performance and market positioning as it continues to navigate the competitive landscape of the biotechnology sector.